发明名称 LYMPHOTOXIN-beta, LYMPHOTOXIN-beta COMPLEX, PHARMACEUTICAL PREPARATION AND THERAPEUTIC USE THEREOF
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a lymphotoxin-β, a lymphocyte membrane type protein, or a complex formed between lymphotoxin-βand other peptide such as lymphotoxin-αand a complex comprising multiple subunits of lymphotoxin-β, and set the LT-αformed within the cell hold on the cell surface by using these proteins and complexes, where the LT-α/LT-βcomplex may act as an inflammation regulating agent, a tumor growth inhibiting agent, a T cell inhibiting agent, a T cell activating agent, an autoimmune disease regulating agent, or an HIV inhibiting agent, furthermore, the antitumor activity of the LT-α/LT-βcomplex may be delivered to tumor cells by tumor infiltrating lymphocytes (TILs) transfected with the gene for LT-β. <P>SOLUTION: The invention relates to the lymphotoxin-β, a lymphocyte membrane-type polypeptide comprising SEQ ID NO:2. And to the method for alleviating formation of neoplasm. <P>COPYRIGHT: (C)2007,JPO&INPIT</p>
申请公布号 JP2007039464(A) 申请公布日期 2007.02.15
申请号 JP20060253541 申请日期 2006.09.19
申请人 BIOGEN IDEC MA INC;REGENTS OF THE UNIV OF CALIFORNIA 发明人 BROWNING JEFFREY;WARE CARL F
分类号 A61K38/00;C12N15/09;A61K39/395;A61K48/00;A61P29/00;A61P31/12;A61P31/18;A61P35/00;A61P37/02;A61P37/06;A61P43/00;C07H21/04;C07K14/47;C07K14/52;C07K14/525;C07K14/715;C07K19/00;C12N5/10;C12N15/19;C12P21/02;C12R1/91 主分类号 A61K38/00
代理机构 代理人
主权项
地址